Ownership history in XTX Topco Ltd · 10 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in CUE BIOPHARMA INC (CUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 14,741 | -7,752 | -34.5% | 0.00% | $11K | $0.72 |
| 2025 Q2 | REDUCED | 22,493 | -4,451 | -16.5% | 0.00% | $15K | $0.68 |
| 2025 Q1 | REDUCED | 26,944 | -20,029 | -42.6% | 0.00% | $25K | $0.91 |
| 2024 Q4 | ADDED | 46,973 | +19,308 | +69.8% | 0.00% | $51K | $1.09 |
| 2024 Q3 | ADDED | 27,665 | +12,361 | +80.8% | 0.00% | $21K | $0.76 |
| 2023 Q4 | REDUCED | 15,304 | -37,966 | -71.3% | 0.01% | $40K | $2.64 |
| 2023 Q3 | ADDED | 53,270 | +25,821 | +94.1% | 0.02% | $123K | $2.30 |
| 2022 Q3 | REDUCED | 27,449 | -11,394 | -29.3% | 0.02% | $61K | $2.23 |
| 2022 Q2 | ADDED | 38,843 | +3,544 | +10.0% | 0.04% | $97K | $2.49 |
| 2022 Q1 | INITIATED | 35,299 | — | — | 0.08% | $172K | $4.88 |
As of 2025 Q4 — sorted by position size